221 related articles for article (PubMed ID: 12587840)
1. Synergistic cytotoxicity and apoptosis induced in human cholangiocarcinoma cell lines by a combined treatment with tumor necrosis factor-alpha (TNF-alpha) and triptolide.
Panichakul T; Wanun T; Reutrakul V; Sirisinha S
Asian Pac J Allergy Immunol; 2002 Sep; 20(3):167-73. PubMed ID: 12587840
[TBL] [Abstract][Full Text] [Related]
2. Triptolide sensitizes resistant cholangiocarcinoma cells to TRAIL-induced apoptosis.
Panichakul T; Intachote P; Wongkajorsilp A; Sripa B; Sirisinha S
Anticancer Res; 2006; 26(1A):259-65. PubMed ID: 16475706
[TBL] [Abstract][Full Text] [Related]
3. Triptolide and TRAIL combination enhances apoptosis in cholangiocarcinoma.
Clawson KA; Borja-Cacho D; Antonoff MB; Saluja AK; Vickers SM
J Surg Res; 2010 Oct; 163(2):244-9. PubMed ID: 20691980
[TBL] [Abstract][Full Text] [Related]
4. Cyclins D1, E, A expression and synergistic cytotoxicity to a cholangiocarcinoma cell line from recombinant TNF-alpha and PHA supernate.
Vongsakul M; Aksomboon A
Asian Pac J Allergy Immunol; 2002 Mar; 20(1):57-60. PubMed ID: 12125919
[TBL] [Abstract][Full Text] [Related]
5. TNF-alpha induces caspase 3 (CPP 32) dependent apoptosis in human cholangiocarcinoma cell line.
Utaisincharoen P; Tangthawornchaikul N; Ubol S; Chaisuriya P; Sirisinha S
Southeast Asian J Trop Med Public Health; 2000; 31 Suppl 1():167-70. PubMed ID: 11414450
[TBL] [Abstract][Full Text] [Related]
6. Antitumor activity of triptolide against cholangiocarcinoma growth in vitro and in hamsters.
Tengchaisri T; Chawengkirttikul R; Rachaphaew N; Reutrakul V; Sangsuwan R; Sirisinha S
Cancer Lett; 1998 Nov; 133(2):169-75. PubMed ID: 10072166
[TBL] [Abstract][Full Text] [Related]
7. Binding of tumour necrosis factor-alpha (TNF-alpha) to TNF-RI induces caspase(s)-dependent apoptosis in human cholangiocarcinoma cell lines.
Utaisincharoen P; Ubol S; Tangthawornchaikul N; Chaisuriya P; Sirisinha S
Clin Exp Immunol; 1999 Apr; 116(1):41-7. PubMed ID: 10209503
[TBL] [Abstract][Full Text] [Related]
8. Synergistic antitumor effect of triptolide and cisplatin in cisplatin resistant human bladder cancer cells.
Ho JN; Byun SS; Lee S; Oh JJ; Hong SK; Lee SE; Yeon JS
J Urol; 2015 Mar; 193(3):1016-22. PubMed ID: 25229559
[TBL] [Abstract][Full Text] [Related]
9. Synergistic anticancer activity of triptolide combined with cisplatin enhances apoptosis in gastric cancer in vitro and in vivo.
Li CJ; Chu CY; Huang LH; Wang MH; Sheu LF; Yeh JI; Hsu HY
Cancer Lett; 2012 Jun; 319(2):203-213. PubMed ID: 22306340
[TBL] [Abstract][Full Text] [Related]
10. Lovastatin overcomes gefitinib resistance through TNF-α signaling in human cholangiocarcinomas with different LKB1 statuses in vitro and in vivo.
Yang SH; Lin HY; Chang VH; Chen CC; Liu YR; Wang J; Zhang K; Jiang X; Yen Y
Oncotarget; 2015 Sep; 6(27):23857-73. PubMed ID: 26160843
[TBL] [Abstract][Full Text] [Related]
11. Triptolide sensitizes human breast cancer cells to tumor necrosis factor‑α‑induced apoptosis by inhibiting activation of the nuclear factor‑κB pathway.
Cheng X; Shi W; Zhao C; Zhang D; Liang P; Wang G; Lu L
Mol Med Rep; 2016 Apr; 13(4):3257-64. PubMed ID: 26935527
[TBL] [Abstract][Full Text] [Related]
12. Triptolide induces apoptotic cell death of human cholangiocarcinoma cells through inhibition of myeloid cell leukemia-1.
Ding X; Zhang B; Pei Q; Pan J; Huang S; Yang Y; Zhu Z; Lv Y; Zou X
BMC Cancer; 2014 Apr; 14():271. PubMed ID: 24742042
[TBL] [Abstract][Full Text] [Related]
13. Triptolide cooperates with chemotherapy to induce apoptosis in acute myeloid leukemia cells.
Pigneux A; Mahon FX; Uhalde M; Jeanneteau M; Lacombe F; Milpied N; Reiffers J; Belloc F
Exp Hematol; 2008 Dec; 36(12):1648-59. PubMed ID: 18922616
[TBL] [Abstract][Full Text] [Related]
14. Triptolide sensitizes lung cancer cells to TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by inhibition of NF-kappaB activation.
Lee KY; Park JS; Jee YK; Rosen GD
Exp Mol Med; 2002 Dec; 34(6):462-8. PubMed ID: 12526088
[TBL] [Abstract][Full Text] [Related]
15. Functional p53 is required for triptolide-induced apoptosis and AP-1 and nuclear factor-kappaB activation in gastric cancer cells.
Jiang XH; Wong BC; Lin MC; Zhu GH; Kung HF; Jiang SH; Yang D; Lam SK
Oncogene; 2001 Nov; 20(55):8009-18. PubMed ID: 11753684
[TBL] [Abstract][Full Text] [Related]
16. Synergism of cytotoxicity effects of triptolide and artesunate combination treatment in pancreatic cancer cell lines.
Liu Y; Cui YF
Asian Pac J Cancer Prev; 2013; 14(9):5243-8. PubMed ID: 24175808
[TBL] [Abstract][Full Text] [Related]
17. Triptolide enhances the tumoricidal activity of TRAIL against renal cell carcinoma.
Brincks EL; Kucaba TA; James BR; Murphy KA; Schwertfeger KL; Sangwan V; Banerjee S; Saluja AK; Griffith TS
FEBS J; 2015 Dec; 282(24):4747-4765. PubMed ID: 26426449
[TBL] [Abstract][Full Text] [Related]
18. Triptolide induces apoptosis through extrinsic and intrinsic pathways in human osteosarcoma U2OS cells.
Kwon HY; Kim KS; An HK; Moon HI; Kim HJ; Lee YC
Indian J Biochem Biophys; 2013 Dec; 50(6):485-91. PubMed ID: 24772972
[TBL] [Abstract][Full Text] [Related]
19. Triptolide inhibits transcription factor NF-kappaB and induces apoptosis of multiple myeloma cells.
Yinjun L; Jie J; Yungui W
Leuk Res; 2005 Jan; 29(1):99-105. PubMed ID: 15541481
[TBL] [Abstract][Full Text] [Related]
20. Triptolide sensitizes liver cancer cell lines to chemotherapy in vitro and in vivo.
Li Y; Hu S
Panminerva Med; 2014 Sep; 56(3):211-20. PubMed ID: 24352031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
